Effects of protein kinase A and calcium/phospholipid-dependent kinase modulators in the process of HL-60 cell differentiation: their opposite effects between HL-60 cell and K-562 cell differentiation

Cell Growth Differ. 1991 Sep;2(9):415-20.

Abstract

We have previously shown that HL-60 cells treated with 1 alpha, 25-(OH)2D3 in magnesium-deficient medium are committed to differentiate but do not express differentiation-related phenotypes. In the present study, we demonstrated that Mg2+ deprivation blocked the process of differentiation before the induction of lysozyme mRNA and that the process of HL-60 cell differentiation could be divided into two steps, i.e., a commitment step and a phenotypic expression step. We studied the effects of protein kinase A (PKA) and calcium/phospholipid-dependent protein kinase (PKC) modulators at each step. The results indicated that agonists of PKA enhanced both steps but that N-(2-[methylamino]ethyl-5-isoquinolinesulfonamide inhibited them. On the other hand, 1-oleyl-2-acetylglycerol and 12-O-tetradecanoylphorbol-13-acetate enhanced the commitment step but inhibited that of phenotypic expression. Staurosporine and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine inhibited the commitment step and enhanced that of phenotypic expression. These results indicate that PKA acts as a positive regulatory signal and that PKC has a dual role in the process of HL-60 cell differentiation, i.e., as a positive regulatory signal in the commitment step and as a negative one in the phenotypic expression step. Recently, we have also shown that in K-562 cell differentiation into erythroid lineage, PKA may serve as a negative regulatory signal in both steps; however, PKC may act dually, namely as a negative regulatory signal in the commitment step and as a positive one in the phenotypic expression step.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology
  • Calcium / metabolism
  • Cell Differentiation / drug effects*
  • Cell Line / drug effects
  • Cholecalciferol / pharmacology
  • Diglycerides / pharmacology*
  • Enzyme Activation / drug effects
  • Gene Expression Regulation / drug effects
  • Isoquinolines / pharmacology*
  • Leukemia, Promyelocytic, Acute
  • Magnesium / metabolism
  • Muramidase / genetics
  • Phenotype
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism*
  • Protein Kinase Inhibitors
  • Protein Kinases / metabolism*
  • RNA, Messenger / biosynthesis
  • Staurosporine
  • Tetradecanoylphorbol Acetate / pharmacology*

Substances

  • Alkaloids
  • Diglycerides
  • Isoquinolines
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • Cholecalciferol
  • N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
  • 1-oleoyl-2-acetylglycerol
  • Protein Kinases
  • Protein Kinase C
  • Muramidase
  • Staurosporine
  • Magnesium
  • Tetradecanoylphorbol Acetate
  • Calcium